FDMT — 4D Molecular Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for 4D Molecular Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	277	248	214	288	425
Net Total Accounts Receivable
Net Total Receivables	1.49	0.047	0	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	283	256	221	297	435
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.07	29	35.3	31.7	40.6
Long Term Investments
Other Long Term Assets
Total Assets	288	353	262	340	560
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16.7	16.3	15.7	19	29.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	31.9	34.4	30.5	32.1	49.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	256	319	231	308	511
Total Liabilities & Shareholders' Equity	288	353	262	340	560
Total Common Shares Outstanding